Locations:
Search IconSearch

Transoral Robotic Surgery to Treat Head and Neck Cancer (Podcast)

A new single-port system well-suited for oropharyngeal cancer treatment

Human papillomavirus-related cancer of the oral pharynx is the only head and neck cancer still on the rise in the United States. Fortunately, because patients with HPV-related cancer tend to be younger, healthier non-smokers, they have a better prognosis and longer survivorship than patients with HPV-unrelated cancers. That makes transoral robotic surgery an excellent treatment option.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Transoral robotic surgery has become the standard for oropharyngeal cancer over the past decade and has helped de-intensify or reduce the cancer treatment in proper patients,” says Jamie Ku, MD, an otolaryngology head and neck surgeon at Cleveland Clinic specializing in complex cancers.

In a recent episode of Cleveland Clinic’s Head and Neck Innovations podcast, Dr. Ku discusses transoral robotic surgery and other innovations in the field of oropharyngeal cancer. She shares insight on:

  • The evolution of transoral robotic surgery from its original platform to new single-port technology
  • Patient considerations for the procedure
  • The importance of a multidisciplinary team in treating oropharyngeal cancer, including surgeons, radiation oncologists, medical oncologists, speech-language pathologists and others
  • Emerging technologies in oropharyngeal cancer, including the use of biomarkers and precision oncology

Click the podcast player above to listen to the episode now, or read on for a short edited excerpt. Check out more Head and Neck Innovations episodes at clevelandclinic.org/podcasts/head-and-neck-innovations or wherever you get your podcasts.

Excerpt from the podcast

Podcast host Paul Bryson, MD, MBA: Which patients seem to be better candidates for transoral robotic surgery?

Dr. Ku: In order to maximize the benefit of utilizing such a technology like the single port system for transoral robotic surgery, really proper patient selection is the most important factor. In general, the way we view the role of transoral robotic surgery in HPV-related favorable disease patients is really to de-intensify or reduce treatment that is necessary to treat and cure the cancer, but also minimize the side effects.

Advertisement

And so, patients who may benefit from this surgery are those with early-stage smaller tumors with limited lymph node involvement in the neck. And even in patients who do smoke or have HPV-unrelated disease, there's a role for this kind of technology and surgery. Really, the goal is to again, either avoid radiation or chemotherapy or minimize radiation and chemotherapy.

I say usually about 20% to 30% of patients with these oropharyngeal cancers are ideal candidates for this. And, it really takes a multidisciplinary team of head and neck cancer experts to best determine their personalized treatment plan and whether or not transoral robotic surgery will be part of their care plan package.

Advertisement

Related Articles

Pediatrician with child
Setting Standards in the Delivery of Pediatric Cancer Care

Leaders of the Pediatric Cancer Committee discuss new accreditation

Seth Rotz, MD, exams patient's throat during clinical exam
Study Reveals New Clues Into Childhood Cancer Survivors’ Increased Risk of Melanoma

Largest study of its kind identifies three treatment exposures that contribute to risk

Silhouettes of man and woman
February 7, 2025/Cancer/News & Insight
Pharmacokinetics of Many Anticancer Drugs Differ Among Sexes

Slower drug elimination from the body among females may impact safety and efficacy

Young patient with cancer
October 25, 2024/Cancer/News & Insight
Multidisciplinary Care Model Supports Young People with Cancer

Integrated program addresses growing need for comprehensive cancer care among adolescents, young adults and adults under 50 with early onset cancers

Genetic sequencing
September 26, 2024/Cancer
AI Can Help Find Trials for Patients with Rare Cancers

Study demonstrates potential for improving access

Dr. Holly Pederson
July 25, 2024/Cancer/Research
Evaluating Risk Scores for Triple-Negative Breast Cancer in Black Women (Podcast)

Polygenic risk score could help predict who will develop this aggressive breast cancer

Natalie Silver, MD, MS, FACS with researcher
Immunologic Factors Associated with Recurrence Among Patients with HPV-Associated OPSCC

Research aims to better understand the tumor immune micorenvironment

Image showing Dr. Gupta
June 20, 2024/Cancer/Research
Trailblazing Urothelial Cancer Treatments (Podcast)

Platinum-eligible phase 3 trial of enfortumab vedotin and pembrolizumab yields ‘unprecedented data’

Ad